Cancer Cytopathology

Papers
(The TQCC of Cancer Cytopathology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Homage to Georgios Papanikolaou: A pilgrimage to his birthplace54
Spotlight: Rising stars in cytology43
Detection of effusion tumor cells under different storage and processing conditions37
35
32
29
HPV persistence after cervical surgical excision of high‐grade cervical lesions27
Researchers confront a rising tide of cancer misinformation26
Retrospective analysis of HPV infection: Cotesting and HPV genotyping in cervical cancer screening within a large academic health care system24
Spindle cell lesions in cytology: Risks of malignancy and application of the upcoming World Health Organization Reporting System for Soft Tissue Cytopathology24
The negative outlook: Long‐term follow up of ThyroSeq negative and low‐risk nodules20
Beyond the microscope: Solving pathology challenges in low and middle income countries requires a multifaceted and multidisciplinary approach19
Validation of on‐slide immunocytochemistry controls prepared from long‐term preserved prefixed cell suspensions18
Quantifying the hidden impact of COVID‐19 pandemic: The cytology perspective17
“Other” high‐risk HPV: Challenges in anal cancer screening17
Issue Information16
Impact of race, ethnicity, and human immunodeficiency virus status on anal high‐risk HPV subtypes: Preliminary insights from a diverse urban population15
15
Cytology‐Radiology Correlation Series: Pancreatic cytopathology15
Editorial in response to Thangaiah et al.15
Spotlight: Rising stars in cytology15
Issue Information15
Thyroid nodules and cancer: The search for certainty14
Deep targeted sequencing of cytological tumor cells using whole genome amplification14
Issue Information14
Issue Information14
Scrape versus imprint cytology in sentinel lymph nodes of breast cancer patients after neoadjuvant therapy: Does combination add value?14
Cytologic, histologic, and clinical correlation of minor mutations in pancreatic cysts14
Malignant effusions secondary to metastatic thyroid carcinomas: A review of 15 cases13
13
Interventional cytology benefits patients undergoing thyroid FNA13
Generalists and specialists: Two sides of the same coin for cancer care?13
Retrieving new clues about a dog breed’s “insane” cancer risk13
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist12
The birth, life, and death of a cytopathology board examination question12
Cytology of cystic lesions of the pancreas: Practical insights, pearls, and pitfalls12
Assessment of the efficiency and accuracy of an artificial intelligence assistive system in the diagnosis of Pap cervical atypical glandular cell cytology12
Digital Examination of LYmph node CYtopathology Using the Sydney system (DELYCYUS): An international, multi‐institutional study12
High accuracy in detecting HER2‐low status in FNA of primary and metastatic breast cancer12
Utilization of Oil Red O staining for assessing aspiration risk in lung transplant patients: A multidisciplinary prospective study with clinical practice insights12
Parsing the thyroid cytopathology suspicious for malignancy diagnosis through molecular‐derived risk of malignancy and other related parameters: Insights into nodule characteristics and practice patte11
Spotlight: Rising Stars in Cytology11
Issue Information11
Issue Information11
Issue Information11
Introducing Cancer Cytopathology Practice Essentials: A new series of practical and up‐to‐date reviews11
11
Issue Information11
Nuclear membrane irregularity in high‐grade urothelial carcinoma cells can be measured by using circularity and solidity as morphometric shape definitions in digital image analysis of urinary tract cy10
The discordant biomarker dilemma: What are the diagnostic implications of oropharyngeal squamous cell carcinomas with discrepant p16 and HPV results?10
Neutrophil‐calibrated atypical squamous cells in ThinPrep urine cytology for detecting squamous differentiation in urothelial carcinoma10
Pulmonary cytology: Pearls and pitfalls of non‐neoplastic mimics of lung cancer10
Beyond the adult standard: Tailoring the WHO Reporting System for Lymph Node Cytopathology to pediatric diagnostics and management9
DICER1 mutations in Bethesda category II, III, and IV thyroid nodules: A mutually exclusive relationship with BRAFV600E mutation9
Issue Information8
Patient‐facing communication for cytopathologists: A framework for disclosing diagnostic error8
Comparison of conventional and novel rotational FNA needles using conventional microscopy and image analysis to quantitatively assess yield8
p53 expression in cytology samples may represent a marker of early‐stage cancer8
Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with atypical glandular cells cytology: A retrospective analysis of 369 cases8
Calibration of the Becton Dickinson FocalPoint GS slide profiler is essential for optimal performance: Avoiding the algorithm supersaturation cascade effect pitfall8
Artificial intelligence and medicine: Mounting risks amid the promise8
Assessment of stained direct cytology smears of breast cancer for whole transcriptome and targeted messenger RNA sequencing8
Application of CytoMatrix for the diagnosis of melanoma metastases on FNA cytology samples: Performance of a novel cell block method8
Issue Information8
Issue Information8
Cytohistologic immunohistochemical correlation of epithelial tubo‐ovarian neoplasms: Can cell blocks substitute for tissue?8
Utility of ACR TI‐RADS to determine need for repeat FNA in thyroid nodules with nondiagnostic cytology8
Issue Information7
Extended HPV genotyping and dual stain for the triage of primary HPV screen‐positive cases: Practical guidance for the cytopathology laboratory7
The hidden costs of clinical trials7
A simplified molecular method to detect high‐risk HPV using the Aptima HPV assay on head and neck FNA smears7
Genotype profile of HPV in ASC‐H cytology and histologic follow‐up—prevalence, distribution, and risk: A retrospective study of 1414 cases7
Risk of malignancy in renal biopsy: A review7
The “preexisting condition” invention in American health care: The persistence of a potential insurance nightmare7
Crystals and crystalloids in cytopathology: Incidence and importance7
Rapid On‐site Evaluation Practice Variability Appraisal (ROSE PETAL) survey7
7
Revisiting the cytologic features of autoimmune pancreatitis: An institutional experience7
Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases7
7
Issue Information6
6
The diagnostic challenges of medullary thyroid carcinoma: A practical guide for cytopathologists6
Prioritizing parotid gland surgery: A call for the implementation of the MSRSGC classification6
Comprehensive epithelial biomarker analysis of malignant mesothelioma: EpCAM positivity is a potential diagnostic pitfall6
6
Cytologic risk stratification of medullary thyroid carcinoma: Does it make the grade?6
Interobserver agreement in the interpretation of anal cytology6
The digital expression profile of BMP7, CDKN2C, HIST1H3G, and PKMYT1 genes improves high‐grade cervical lesion detection in liquid‐based cytology6
6
6
FNA biopsy of breast specimens effectively harvests cells for patient‐derived organoids modeling ductal carcinoma in situ6
Issue Information5
Issue Information5
A growing brain drain: US policies are spurring medical researchers to pursue other options5
Ultrarapid BRAF mutation detection on supernatant cell‐free DNA obtained by FNA: An accurate and expedient method for BRAF 5
Prediction of lymphocyte‐predominant breast cancer using microRNA expression in cytology specimens5
Cytologic diagnosis of fumarate hydratase‐deficient renal cell carcinoma: A single‐institutional experience5
Utility of high‐risk HPV RNA chromogenic in situ hybridization in cytology smears and liquid‐based preparations from metastatic head and neck squamous cell carcinoma5
Thyroid FNA cytology: Impact of the COVID‐19 pandemic and vaccination in a Brazilian series5
Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology5
Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine cytology5
Follicular neoplasms with nuclear atypia versus other types of atypia: Should follicular neoplasms be stratified according to the presence of nuclear atypia?5
Atypia of undetermined significance and ThyroSeq v3–positive call rates as quality control metrics for cytology laboratory performance5
The new endocrine WHO classification: What does this mean for thyroid cytology?5
A pilot study: Comparison of TRPS1 and GATA3 immunoperoxidase staining using cytologic smears in entities reportedly positive for GATA35
Issue Information5
Spotlight: Rising stars in cytology5
Dual immunocytochemical staining of annexin A10 and p53 in low‐grade and papillary urothelial carcinoma contributes to improvement of diagnostic accuracy in urine cytology5
Artificial intelligence–assisted urine cytology based on the Paris System for Reporting Urothelial Carcinoma5
Repurposed drugs may lend a new hand as add‐ons to existing cancer treatments5
Cytomorphologic and molecular characterization of spindle cell carcinoid tumors of the lung5
The value of monitoring amended reports in cytopathology quality programs: A biennial review5
Artificial intelligence in nongynecologic cytology: A systematic review of current research and commercial tools4
Molecular profiling of thyroid nodules on cytologic samples: Findings from an Italian multi‐institutional cohort4
Emerging role of blood‐based biomarker testing in HPV‐mediated head and neck squamous cell carcinoma4
Issue Information4
The role of cytology in densely populated territories: An experience from Hong Kong4
Practical implications of the World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Categories and ancillary testing for subtyping of hematolymphoid tumors on FN4
Correction to “The fascinating history of papillary thyroid carcinoma nuclei: revelation of two nuclear morphologies—“Classical papillary” and “papillary‐like”, with different pathobiologic characteri4
Use of nongynecologic cytologic–histologic correlation to identify patterns of error: An institutional experience4
The rise of biopolitics as a growing force in medicine4
Bridging the gap to the next generation of learners and column leadership4
New chances and challenges for preventing HPV‐associated throat cancer4
The power and pitfalls of using social media to study rare cancers4
Disappearing act: The US retreat on research funding is dimming the future of international cancer research4
4
Writing our way through academia: Our journey as young faculty and book authors4
Clinicopathological and molecular characterization of non–small cell lung cancer with pericardial effusions4
Diagnostic challenges in urinary cytology: Practical insights from The Paris System for Reporting Urinary Cytology4
How an epidemic of untreated malnutrition is worsening cancer4
Diagnostic implication of extracellular mucin in pancreatic/biliary brushing and stent cytology4
Diagnostic utility of p53, SMAD4, and the novel biomarker PON2 in FNA of pancreatic ductal adenocarcinoma4
Fluorescence in situ hybridization for ETV6 gene rearrangements on destained cytological smears: Role in diagnosis of secretory carcinoma of salivary gland4
Current role of cytopathology in the molecular and computational era: The perspective of young pathologists4
Interobserver agreement and risk of malignancy using the International Academy of Cytology Yokohama System for reporting breast FNA biopsy in a liquid‐based exclusive cohort4
Evaluating the role of metaplasia in the cytologic diagnosis of pleomorphic adenoma: A multi‐institutional study of 253 cases4
What quality‑assurance metrics best assess the diagnostic performance of pathologists in thyroid fine‑needle aspiration cytology?4
0.62219500541687